Cetera Investment Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cetera Investment Advisers’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$894K	Sell	52,694 -86,763	-62%	-$1.39M	﹤0.01%	3152
2026 Q1	$2.07M	Sell	139,457 -12,546	-8%	-$183K	﹤0.01%	2256
2025 Q4	$2.42M	Buy	152,003 +94,194	+163%	+$1.34M	﹤0.01%	2044
2025 Q3	$639K	Sell	57,809 -3,657	-6%	-$39.9K	﹤0.01%	3180
2025 Q2	$521K	Sell	61,466 -993	-2%	-$7.96K	﹤0.01%	2942
2025 Q1	$502K	Sell	62,459 -2,179	-3%	-$17.7K	﹤0.01%	2839
2024 Q4	$580K	Buy	64,638 +2,000	+3%	+$16.3K	﹤0.01%	2564
2024 Q3	$459K	Buy	62,638 +150	+0.2%	+$930	﹤0.01%	2714
2024 Q2	$357K	Buy	62,488 +1,103	+2%	+$5.81K	﹤0.01%	2879
2024 Q1	$308K	Buy	+61,385	New	+$416K	﹤0.01%	3017

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's AUPH Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Aurinia Pharmaceuticals (AUPH) stake by 62% in Q2 2026, selling an estimated $1.39M and leaving 52,694 shares worth $894K. The position accounts for ﹤0.01% of the portfolio, ranked #3152.

Cetera Investment Advisers first reported a position in AUPH in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.42M in Q4 2025. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Cetera Investment Advisers held 52,694 shares of Aurinia Pharmaceuticals worth $894K as of Q2 2026.
Cetera Investment Advisers sold 86,763 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $1.39M.
Aurinia Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3152 holding.
Cetera Investment Advisers first reported a position in Aurinia Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Cetera Investment Advisers's Aurinia Pharmaceuticals position peaked at $2.42M in Q4 2025.
281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.